List of Surgical Devices Companies in New York - 4

Perfecting the Sense of Sight. Clerio Vision is developing a revolutionary product platform for the global ophthalmic market, based on technology licensed from the University of Rochester. The company is in the process of developing and commercializing a portfolio of next generation products in contact lenses, myopia control and cataract surgery. The team is composed of serial entrepreneurs with multiple exits as well as ophthalmic industry veterans who pioneered a number of new ophthalmic technology categories. The products are currently in clinical development.

LSI SOLUTIONS®, located in beautiful Victor, New York, is a dynamic and growing medical device company that has more than doubled in size over the last seven years. - LSI SOLUTIONS® is dedicated to advancing minimally invasive therapeutics through research, development, manufacturing, and marketing proprietary products. - Company Mission: Our customer is ultimately a patient. Our technology challenges human illness. Our mission is to lead the world in surgical innovation and product delivery.

PAVmed (NASDAQ: PAVM) is a highly-differentiated, multi-product medical device company employing a unique and proven business model designed to advance products from concept to commercialization much more rapidly and with significantly less capital than the typical medical device company. This model enables us to pursue an expanding pipeline strategy with a view to enhancing and accelerating value creation.

ReVivo Medical, LLC is an early-stage medical device development company. Our initial focus is on an array of implantable devices capable of improving treatments for back and neck pain. Our unique designs rely on the biomechanics of load sharing to promote bone fusion. They have been designed with the challenges of the surgical procedure in mind. Market Background. Lower back and neck pain are the leading causes of disability world-wide. In the United States alone, there are more than 465,000 spinal fusion surgeries (of all types) performed each year. Most conventional surgeries use interbody cages that fill the space between the vertebrae and plates (akin to splints) that are implanted to hold the vertebrae in place while the spine heals. Worldwide, the spinal fusion device market is $6.4 billion. With the current economics of medicine in the United States, additional challenges have been placed on spine surgeons. Reimbursement rates are reduced and are often tied to outcomes. Surgeons need to constantly improve their results and be more efficient in the operating room, thus they are seeking new products which add value while reducing cost. Customer Value Proposition. Our initial two flagship products, an interbody cervical cage and an anterior cervical plate are innovative, next generation designs. It is anticipated that they will:  Accelerate patient recovery time.  Reduce the complexity and time required for surgery.  Achieve manufacturing costs comparable to premium implants.  Have greater appeal than the commonly used PEEK material (for our cages).